Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group
Autor: | Sandra Orrù, Rubina Manuela Trimboli, Fiorenza De Rose, Fabio Puglisi, Carlo Cabula, A. Ciabattoni, Lucia Da Ros, Massimo Maria Grassi, Isabella Castellano, Bruno Meduri |
---|---|
Rok vydání: | 2021 |
Předmět: |
Breast cancer
Hypofractionated radiotherapy Multidisciplinary review Partial breast irradiation Cancer Research medicine.medical_specialty Specialty Breast Neoplasms 03 medical and health sciences 0302 clinical medicine Whole Breast Irradiation Multidisciplinary approach Humans Medicine Medical physics skin and connective tissue diseases Mastectomy Radiation oncologist Surgeons business.industry Cancer Partial Breast Irradiation Hematology General Medicine medicine.disease Carcinoma Intraductal Noninfiltrating Oncology 030220 oncology & carcinogenesis Female Radiation Dose Hypofractionation business |
Zdroj: | Medical Oncology. 38 |
ISSN: | 1559-131X 1357-0560 |
DOI: | 10.1007/s12032-021-01514-w |
Popis: | The multidisciplinary management represents a crucial part of the care for cancer patients, resulting in better clinical and process outcomes, with evidence of improved survival among different cancer primary sites, including breast. According with international recommendations established by the European Society of Breast Cancer Specialists (EUSOMA), all breast-cancer patients have to be evaluated by a multidisciplinary team including radiologist, pathologist, surgeon, medical oncologist and radiation oncologist. Thus, variations in clinical practice of each specialty should be discussed and shared with all team members to guarantee a fruitful cooperation among the involved specialists. During the last decades, radiation treatment was deeply changed by the evidence-based adoption of hypofractionated radiotherapy (HFRT) as standard of treatment in patients with early-stage breast cancer undergoing conservative surgery. Moreover, mature randomized data have showed that partial breast irradiation (PBI) is an effective and safe alternative to whole breast irradiation in selected patients with low-risk early-stage breast cancer. Based on this background, we reviewed indications and critical issues of HFRT and PBI analyzing impact of their adoption from a multidisciplinary perspective. |
Databáze: | OpenAIRE |
Externí odkaz: |